PJT's 1-year price change of -2.3% indicates a mild downtrend, contrasting with the S&P 500's 19.1% gain, reflecting relative underperformance. The stock currently trades at $162.99, approximately 83% of its 52-week range (low $127.73, high $195.62), positioning it closer to the midpoint but below the highs, suggesting a recovery from lows but lacking strong upward momentum. Over the past 3 months, PJT has rallied 16.4%, significantly outperforming the S&P 500's 13.6% gain, indicating a short-term recovery. However, the 1-month change of 4.0% shows decelerating momentum compared to the 3-month surge, potentially signaling a pause or consolidation. The stock's beta of 0.84 implies lower volatility than the market, which may appeal to risk-averse investors but also limits upside participation in strong markets. Key support lies near the 52-week low of $127.73, while resistance is at the 52-week high of $195.62. A breakout above $195.62 would signal a resumption of the long-term uptrend, while a breakdown below $127.73 could indicate further downside. The current price is well above the low, suggesting the stock is in a recovery phase but still far from challenging resistance.

PJT's revenue trajectory appears stable, with estimated annual revenue of $2.36 billion for the current fiscal year, though specific quarterly figures are unavailable. The company's net margin of 10.5% indicates profitability, and the gross margin of 32.4% reflects a healthy advisory business model. Operating margin of 21.2% suggests strong cost control, though margin trends over recent quarters cannot be assessed due to missing data. Net income is positive, with an EPS of $0.04 (likely quarterly), confirming profitability. The ROE of 58.4% is exceptionally high, indicating efficient use of equity capital, while ROA of 21.9% underscores strong asset utilization. The debt-to-equity ratio of 1.34 suggests moderate leverage, but the current ratio of 27.7 indicates ample liquidity. Free cash flow data is not provided, but the PCF ratio of 8.2x implies reasonable cash flow generation relative to market cap. Overall, PJT appears financially healthy with strong profitability and liquidity, though the high debt-to-equity warrants monitoring in a rising rate environment.